Novel coumarin derivatives bearing N-benzyl pyridinium moiety: Potent and dual binding site acetylcholinesterase inhibitors

A novel series of coumarin derivatives linked to benzyl pyridinium group were achieved as potent and dual binding site acetylcholinesterase inhibitors. A novel series of coumarin derivatives linked to benzyl pyridinium group were synthesized and biologically evaluated as inhibitors of both acetylcho...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 20; no. 24; pp. 7214 - 7222
Main Authors Alipour, Masoumeh, Khoobi, Mehdi, Foroumadi, Alireza, Nadri, Hamid, Moradi, Alireza, Sakhteman, Amirhossein, Ghandi, Mehdi, Shafiee, Abbas
Format Journal Article
LanguageEnglish
Published OXFORD Elsevier Ltd 15.12.2012
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A novel series of coumarin derivatives linked to benzyl pyridinium group were achieved as potent and dual binding site acetylcholinesterase inhibitors. A novel series of coumarin derivatives linked to benzyl pyridinium group were synthesized and biologically evaluated as inhibitors of both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The enzyme inhibitory activity of synthesized compounds was measured using colorimetric Ellman’s method. It was revealed that compounds 3e, 3h, 3l, 3r and 3s have shown higher activity compared with donepezil hydrochloride as standard drug. Most of the compounds in these series had nanomolar range IC50 in which compound 3r (IC50=0.11nM) was the most active compound against acetylcholinesterase enzyme.
Bibliography:http://dx.doi.org/10.1016/j.bmc.2012.08.052
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2012.08.052